11-124923786-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_152722.5(HEPACAM):​c.652A>G​(p.Met218Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.715 in 1,613,966 control chromosomes in the GnomAD database, including 415,256 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M218T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.76 ( 44418 hom., cov: 32)
Exomes 𝑓: 0.71 ( 370838 hom. )

Consequence

HEPACAM
NM_152722.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.220

Publications

30 publications found
Variant links:
Genes affected
HEPACAM (HGNC:26361): (hepatic and glial cell adhesion molecule) The protein encoded by this gene is a single-pass type I membrane protein that localizes to the cytoplasmic side of the cell membrane. The encoded protein acts as a homodimer and is involved in cell motility and cell-matrix interactions. The expression of this gene is downregulated or undetectable in many cancer cell lines, so this may be a tumor suppressor gene. [provided by RefSeq, Jul 2011]
HEPACAM Gene-Disease associations (from GenCC):
  • megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without intellectual disability
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • megalencephalic leukoencephalopathy with subcortical cysts 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • macrocephaly-autism syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • megalencephalic leukoencephalopathy with subcortical cysts
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.1099867E-6).
BP6
Variant 11-124923786-T-C is Benign according to our data. Variant chr11-124923786-T-C is described in ClinVar as Benign. ClinVar VariationId is 262681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.88 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HEPACAMNM_152722.5 linkc.652A>G p.Met218Val missense_variant Exon 3 of 7 ENST00000298251.5 NP_689935.2
HEPACAMNM_001411043.1 linkc.652A>G p.Met218Val missense_variant Exon 3 of 7 NP_001397972.1
HEPACAMNM_001441320.1 linkc.652A>G p.Met218Val missense_variant Exon 3 of 7 NP_001428249.1
LOC107984406XR_001748429.3 linkn.335-19614T>C intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HEPACAMENST00000298251.5 linkc.652A>G p.Met218Val missense_variant Exon 3 of 7 1 NM_152722.5 ENSP00000298251.4

Frequencies

GnomAD3 genomes
AF:
0.759
AC:
115386
AN:
152108
Hom.:
44366
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.875
Gnomad AMI
AF:
0.764
Gnomad AMR
AF:
0.674
Gnomad ASJ
AF:
0.638
Gnomad EAS
AF:
0.902
Gnomad SAS
AF:
0.749
Gnomad FIN
AF:
0.778
Gnomad MID
AF:
0.706
Gnomad NFE
AF:
0.700
Gnomad OTH
AF:
0.746
GnomAD2 exomes
AF:
0.722
AC:
181481
AN:
251320
AF XY:
0.722
show subpopulations
Gnomad AFR exome
AF:
0.881
Gnomad AMR exome
AF:
0.607
Gnomad ASJ exome
AF:
0.639
Gnomad EAS exome
AF:
0.892
Gnomad FIN exome
AF:
0.769
Gnomad NFE exome
AF:
0.700
Gnomad OTH exome
AF:
0.701
GnomAD4 exome
AF:
0.710
AC:
1037907
AN:
1461740
Hom.:
370838
Cov.:
60
AF XY:
0.711
AC XY:
516897
AN XY:
727170
show subpopulations
African (AFR)
AF:
0.879
AC:
29425
AN:
33476
American (AMR)
AF:
0.614
AC:
27472
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.638
AC:
16677
AN:
26136
East Asian (EAS)
AF:
0.910
AC:
36119
AN:
39700
South Asian (SAS)
AF:
0.744
AC:
64215
AN:
86256
European-Finnish (FIN)
AF:
0.766
AC:
40883
AN:
53406
Middle Eastern (MID)
AF:
0.714
AC:
4118
AN:
5766
European-Non Finnish (NFE)
AF:
0.697
AC:
775366
AN:
1111884
Other (OTH)
AF:
0.722
AC:
43632
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
17187
34374
51561
68748
85935
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19714
39428
59142
78856
98570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.759
AC:
115502
AN:
152226
Hom.:
44418
Cov.:
32
AF XY:
0.763
AC XY:
56781
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.875
AC:
36373
AN:
41562
American (AMR)
AF:
0.674
AC:
10313
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.638
AC:
2215
AN:
3472
East Asian (EAS)
AF:
0.902
AC:
4661
AN:
5168
South Asian (SAS)
AF:
0.750
AC:
3618
AN:
4822
European-Finnish (FIN)
AF:
0.778
AC:
8244
AN:
10592
Middle Eastern (MID)
AF:
0.714
AC:
210
AN:
294
European-Non Finnish (NFE)
AF:
0.700
AC:
47592
AN:
67998
Other (OTH)
AF:
0.749
AC:
1581
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1433
2865
4298
5730
7163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
852
1704
2556
3408
4260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.717
Hom.:
132133
Bravo
AF:
0.755
TwinsUK
AF:
0.717
AC:
2659
ALSPAC
AF:
0.703
AC:
2711
ESP6500AA
AF:
0.878
AC:
3864
ESP6500EA
AF:
0.687
AC:
5911
ExAC
AF:
0.728
AC:
88427
Asia WGS
AF:
0.849
AC:
2954
AN:
3478
EpiCase
AF:
0.699
EpiControl
AF:
0.694

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Megalencephalic leukoencephalopathy with subcortical cysts 2A Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without intellectual disability Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Megalencephalic leukoencephalopathy with subcortical cysts Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.050
BayesDel_addAF
Benign
-0.87
T
BayesDel_noAF
Benign
-0.88
CADD
Benign
10
DANN
Benign
0.82
DEOGEN2
Benign
0.014
T
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.64
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.13
T
MetaRNN
Benign
0.0000011
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-0.47
N
PhyloP100
0.22
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.24
N
REVEL
Benign
0.052
Sift
Benign
0.83
T
Sift4G
Benign
0.75
T
Polyphen
0.0
B
Vest4
0.029
MPC
0.31
ClinPred
0.00073
T
GERP RS
2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.052
gMVP
0.29
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10790715; hg19: chr11-124793682; COSMIC: COSV99035985; COSMIC: COSV99035985; API